(Reuters) -Strong results from AstraZeneca helped London's blue-chip index notch a record close on Thursday, while a dovish ...
A Liberal Democrat peer has accused the government of favouring the south-east of England over Merseyside after AstraZeneca ...
AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue ...
Pharma giant AstraZeneca urged Britain to improve the environment for businesses in order to drive investment, days after it ...
The pharmaceuticals major was boosted by high demand for its key drugs that offset a slight sales drop in China.
AstraZeneca could face a fine of up to $4.5 million in China over suspected unpaid taxes related to the import of two of its ...
AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...
LONDON — Pharmaceutical company AstraZeneca on Friday cancelled a planned 450 million-pound ($560 million) investment in a ...
AstraZeneca stock rose early Thursday after the drugmaker beat fourth-quarter earnings views and delivered upbeat guidance.
Buying Alexion remains a “fantastic acquisition” for AstraZeneca, the Big Pharma’s CEO has said, even as the company takes a ...
AstraZeneca on Thursday warned that it could be fined millions of dollars in importation tax fines as Chinese authorities ...
The boss of AstraZeneca Plc said he does not believe the UK is the worst place to invest, striking a conciliatory tone just ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results